| Literature DB >> 23935596 |
Dariusz Wasyl1, Andrzej Hoszowski, Magdalena Zając, Krzysztof Szulowski.
Abstract
Monitoring of antimicrobial resistance in commensal Escherichia coli (N = 3430) isolated from slaughtered broilers, laying hens, turkeys, swine, and cattle in Poland has been run between 2009 and 2012. Based on minimal inhibitory concentration (MIC) microbiological resistance to each of 14 tested antimicrobials was found reaching the highest values for tetracycline (43.3%), ampicillin (42.3%), and ciprofloxacin (39.0%) whereas the lowest for colistin (0.9%), cephalosporins (3.6 ÷ 3.8%), and florfenicol (3.8%). The highest prevalence of resistance was noted in broiler and turkey isolates, whereas it was rare in cattle. That finding along with resistance patterns specific to isolation source might reflect antimicrobial consumption, usage preferences or management practices in specific animals. Regression analysis has identified changes in prevalence of microbiological resistance and shifts of MIC values. Critically important fluoroquinolone resistance was worrisome in poultry isolates, but did not change over the study period. The difference (4.7%) between resistance to ciprofloxacin and nalidixic acid indicated the scale of plasmid-mediated quinolone resistance. Cephalosporin resistance were found in less than 3.8% of the isolates but an increasing trends were observed in poultry and MIC shift in the ones from cattle. Gentamycin resistance was also increasing in E. coli of turkey and cattle origin although prevalence of streptomycin resistance in laying hens decreased considerably. Simultaneously, decreasing MIC for phenicols observed in cattle and layers isolates as well as tetracycline values in E. coli from laying hens prove that antimicrobial resistance is multivariable phenomenon not only directly related to antimicrobial usage. Further studies should elucidate the scope of commensal E. coli as reservoirs of resistance genes, their spread and possible threats for human and animal health.Entities:
Keywords: Escherichia coli; antimicrobial resistance; commensal; indicator bacteria; resistance phenotypes; resistance trends
Year: 2013 PMID: 23935596 PMCID: PMC3733020 DOI: 10.3389/fmicb.2013.00221
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Descriptive characteristics of studied populations relevant for sampling planning, number of samples collected and .
| Number of animals slaughtered in Poland | Broilers | 554846197 | 578970522 | 633640413 | 666313527 | 723764340 |
| Layers | 29550379 | 26353151 | 33890429 | 37311263 | 39056653 | |
| Turkeys | 27244356 | 22926577 | 25339326 | 25287042 | 27780566 | |
| Swine | 19525920 | 17420288 | 19488804 | 20038278 | 20094157 | |
| Cattle | 1601569 | 1492360 | 1580467 | 1523384 | 1578773 | |
| Number of slaughterhouses in Poland | Broilers | 178 | 159 | 160 | 156 | 155 |
| Layers | 51 | 44 | 43 | 40 | 37 | |
| Turkeys | 37 | 34 | 29 | 26 | 24 | |
| Swine | 912 | 706 | 694 | 682 | 662 | |
| Cattle | 440 | 355 | 349 | 351 | 340 | |
| Slaughter capacity threshold | Broilers | 3650000 | 2200000 | 2100000 | 2 200 000 | |
| Layers | 70000 | 100000 | 50000 | 30 000 | ||
| Turkeys | 700000 | 250000 | 100000 | 90 000 | ||
| Swine | 19300 | 35000 | 39000 | 45 000 | ||
| Cattle | 3600 | 4750 | 4800 | 4 950 | ||
| Number of abattoirs designated for sampling and their contribution to annual slaughter capacity (%) | Broilers | 47 (80%) | 61(85%) | 66 (90%) | 63 (90%) | |
| Layers | 7 (50%) | 20 (95%) | 20 (99%) | 27 (99%) | ||
| Turkeys | 15 (80%) | 21 (95%) | 23 (99%) | 22 (99%) | ||
| Swine | 200 (80%) | 109 (70%) | 94 (70%) | 81 (70%) | ||
| Cattle | 91 (80%) | 79 (80%) | 78 (80%) | 72 (80%) | ||
| Number of samples collected and proceeded | Broilers | 180 | 186 | 192 | 195 | |
| Layers | 162 | 194 | 181 | 179 | ||
| Turkeys | 180 | 188 | 194 | 189 | ||
| Swine | 181 | 176 | 189 | 194 | ||
| Cattle | 174 | 179 | 176 | 191 | ||
| Number of tested | Broilers | 171 | 170 | 170 | 171 | |
| Layers | 157 | 169 | 155 | 157 | ||
| Turkeys | 173 | 170 | 170 | 180 | ||
| Swine | 178 | 170 | 172 | 190 | ||
| Cattle | 173 | 171 | 173 | 190 | ||
Minimal number of animals slaughtered at abattoir to consider designation of slaughterhouse for sampling.
Estimated contribution (%) of designated abattoirs to annual national production of slaughtered animals.
Minimal inhibitory concentration distribution of .
White zones display the applied dilutions ranges. Vertical line indicates interpretative criteria (EUCAST epidemiological values).
.
Figure 1Microbiological resistance to beta-lactams and cephalosporins.
Figure 6Microbiological resistance to tetracycline.
Figure 2Microbiological resistance to quinolones and fluroquinolones.
Figure 3Microbiological resistance to phenicols.
Figure 4Microbiological resistance to aminoglycosides.
Figure 5Microbiological resistance to folate-path inhibitors.
The 18 most common resistance patterns found in .
| AmpNalCipStrSmxTmpTcy | 64 [47%] | 14 | 51 [38%] | 4 | 3 | 136 |
| NalCip | 40 [31%] | 65 [50%] | 22 | 2 | 2 | 131 |
| Tcy | 8 | 12 | 29 | 48 [44%] | 13 | 110 |
| AmpNalCipTcy | 31 [37%] | 17 | 32 [39%] | 2 | 1 | 83 |
| Smx | 4 | 15 | 11 | 14 | 33 [43%] | 77 |
| Amp | 11 | 22 [37%] | 2 | 17 | 7 | 59 |
| StrTcy | 4 | 4 | 42 [75%] | 6 | 56 | |
| AmpTcy | 11 | 12 | 24 [44%] | 6 | 1 | 54 |
| AmpNalCip | 21 [43%] | 16 [33%] | 11 | 1 | 49 | |
| AmpStrSmxTmpTcy | 14 [32%] | 3 | 7 | 17 [39%] | 3 | 44 |
| StrSmxTcy | 1 | 1 | 34 [79%] | 7 | 43 | |
| AmpNalCipChlStrSmxTmpTcy | 16 [39%] | 4 | 21 [51%] | 41 | ||
| AmpNalCipStrTcy | 16 [42%] | 7 | 12 [32%] | 3 | 38 | |
| Str | 2 | 1 | 30 [88%] | 1 | 34 | |
| AmpNalCipStrSmxTcy | 17 [50%] | 5 | 10 | 2 | 34 | |
| AmpNalCipSmxTmpTcy | 25 [74%] | 3 | 6 | 34 | ||
| AmpStrSmxTcy | 9 | 7 | 14 [42%] | 3 | 33 | |
| AmpNalCipStrKanSmxTmpTcy | 17 [57%] | 1 | 9 | 2 | 1 | 30 |
Percentage of the isolates representing a profile is shown if ≥ 30%.
Complexity of resistance patterns by source of .
| Wild-type (no resistance) | % | 5.1% | 39.3% | 11.3% | 35.9% | 79.9% | 34.5% |
| 95% CI | 3.5 ÷ 6.8% | 35.6 ÷ 43.1% | 8.9 ÷ 13.6% | 32.4 ÷ 39.4% | 77.0 ÷ 82.9% | 32.9 ÷ 36.1% | |
| Multi-drug resistance (≥3 antimicrobial classes) | % | 80.6% | 31.0% | 70.3% | 33.7% | 9.1% | 44.8% |
| 95% CI | 77.7 ÷ 83.6% | 27.4 ÷ 34.6% | 66.9 ÷ 73.7% | 30.2 ÷ 37.1% | 6.9 ÷ 11.2% | 43.2 ÷ 46.5% | |
| Extensive-drug resistance (7 ÷ 9 antimicrobial classes) | % | 11.7% | 3.3% | 13.3% | 0.8% | 0.3% | 5.9% |
| 95% CI | 9.3 ÷ 14.1% | 1.9 ÷ 4.7% | 10.7 ÷ 15.8% | 0.2 ÷ 1.5% | 0.0 ÷ 0.7% | 5.1 ÷ 6.6% | |
| Pan-drug resistance (8 ÷ 9 antimicrobial classes) | % | 1.6% | 0.2% | 1.9% | 0.1% | 0.0% | 0.8% |
| 95% CI | 0.7 ÷ 2.6% | 0.0 ÷ 0.5% | 0.9 ÷ 2.9% | 0.0 ÷ 0.4% | 0.0 ÷ 0.0% | 0.5 ÷ 1.0% | |